Myriad Genetics | MYGN - 負債





負債 変化する 日付
Agilent USD 3.35B 0 2025-12
Becton, Dickinson and Co. USD 19.54B 358M 2025-12
Bio-Rad Laboratories USD 1.39B 9.2M 2025-12
Bruker USD 2.04B 34.4M 2025-12
Danaher USD 18.48B 66M 2026-03
Illumina USD 2.55B 23M 2025-12
J&J USD 47.93B 2.14B 2025-12
Mettler Toledo International USD 2.15B 57.69M 2025-12
Myriad Genetics USD 59.3M 19.7M 2025-03
OraSure Technologies USD 782K 465K 2024-06
Pacific Biosciences Of California USD 892.24M 653K 2023-12
Quest Diagnostics USD 6.41B 179M 2026-03
Quidel USD 2.83B 9.9M 2025-12
Repligen USD 546.58M 4.37M 2026-03
Revvity USD 3.4B 29.2M 2025-12
Standard Biotools USD 27.39M 1.23M 2025-09
Thermo Fisher Scientific USD 39.39B 3.7B 2025-12
Veracyte USD 39.65M 799K 2025-12
Waters USD 1.49B 4.92M 2025-12